Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT02848768
Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma
Sponsor: Rennes University Hospital
View on ClinicalTrials.gov
Summary
The purpose of this study is to validate of a predictive nomogram of response or resistance to targeted therapies in metastatic clear cell renal cell carcinoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
45
Start Date
2014-12
Completion Date
2017-09-21
Last Updated
2026-06-22
Healthy Volunteers
No
Interventions
DRUG
Sunitinib
Locations (1)
CHU de Rennes
Rennes, France